Thibault Vosselman

Artiklar

Article: MOLECULAR PHARMACEUTICS. 2025
Engineered Peptide Coacervates Enable Efficient Intracellular Delivery of the MYC Inhibitor omoMYC
Cerrato CP; Krkoska M; Sun Y; Liano-Pons J; Neo QY; Vosselman T; Alzrigat M; Vojtesek B; Lane DP; Henriksson MA; Miserez A; Landreh M
Article: NATURE COMMUNICATIONS. 2024;15(1):1865
A druggable conformational switch in the c-MYC transactivation domain
Lama D; Vosselman T; Sahin C; Liano-Pons J; Cerrato CP; Nilsson L; Teilum K; Lane DP; Landreh M; Arsenian Henriksson M
Article: MOLECULAR & CELLULAR PROTEOMICS. 2022;21(10):100413
Mass Spectrometry and Machine Learning Reveal Determinants of Client Recognition by Antiamyloid Chaperones
Osterlund N; Vosselman T; Leppert A; Graslund A; Jornvall H; Ilag LL; Marklund EG; Elofsson A; Johansson J; Sahin C; Landreh M
Article: STRUCTURE. 2022;30(5):733-742.e7
A "spindle and thread"mechanism unblocks p53 translation N-terminal disorder
Kaldmae M; Vosselman T; Zhong X; Lama D; Chen G; Saluri M; Kronqvist N; Siau JW; Ng AS; Ghadessy FJ; Sabatier P; Vojtesek B; Sarr M; Sahin C; Osterlund N; Ilag LL; Vaananen VA; Sedimbi S; Arsenian-Henriksson M; Zubarev RA; Nilsson L; Koeck PJB; Rising A; Abelein A; Fritz N; Johansson J; Lane DP; Landreh M